Details

Last Funding Type

Series B

Last Funding Money Raised

€5M

Industries

Biotechnology,Genetics,Life Science

Founded date

Jan 1, 2001

Number Of Employee

1 - 10

Operating Status

Active

Cilian is an emerging biotechnology company developing and marketing a novel expression system. The Company uses a species of Ciliates, a eukaryotic single-cell organism, for the production of enzymes and therapeutic proteins. While Ciliates secrete a number of therapeutically relevant enzymes with high expression rates by nature, recombinant proteins are produced by Ciliates using genetically modified cells.
Leveraging the unique capabilities of the Ciliates, the Company aims to produce proteins at an unmatched quality and price, thereby fulfilling
its mission to improve human health by facilitating access to biopharmaceuticals.